ICON Public Limited Company logo ICLR - ICON Public Limited Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 17
HOLD 11
SELL 2
STRONG
SELL
0
| PRICE TARGET: $164.08 DETAILS
HIGH: $207.00
LOW: $100.00
MEDIAN: $170.00
CONSENSUS: $164.08
DOWNSIDE: 1.01%

About ICON Public Limited Company (https://www.iconplc.com)

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

Key Executives

NAME TITLE DOB SALARY
Steve Empoliti Chief Commercial Officer $2,512,000 USD
Barry Balfe Chief Executive Officer & Director 1979 $985,000 USD
Nigel Clerkin Chief Financial Officer 1974 $741,000 USD
John Climax Founder & Independent Non-Executive Director 1953 $100,000 USD
David Green Vice President of Marketing
Diarmaid Cunningham Chief Administrative Officer, General Counsel & Company Secretary 1975
Joe Cronin Chief Human Resources Officer
Lyons Emer Chief Accounting Officer
Niamh Murphy Director of Corporate Communications
Simon Holmes President of Corporate Investments & Partnerships 1967
Thomas N. O'Leary Chief Information Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.